Clinical evaluation of the effect of Siddha classical drug the Uththaamani nei for the treatment of Gastro Enteritis

Clinical evaluation of the effect of the UTHTHAAMANI NEI nei for the treatment of SERIYA MAANTHAM.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029903

Enrollment

Registered

2020-12-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: UTHTHAMANI NEI: Should be administered 1.5 ml orally twice a day for a period of 7days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 1-7 years 2. Sex: both male and female children 3. Abdominal distension. 4. Abdominal discomfort. 5. Abdominal pain. 6. Fever. 7. Nausea. 8. Vomiting. 9. Willing for admission and study in IPD or Willing to attend OPD.

Exclusion criteria

Exclusion criteria: 1.Children below 1 year and above 7 years. 2.Acute abdominal pain. 3.Intestinalobstruction. 4.Intussusception. 5.Abdominal Pain associated with visible peristalsis 6.Abdominal pain due to systemic illness. 7.Abdominal pain due to inflammatory bowel disease.

Design outcomes

Primary

Measure	Time frame
Decreasing symptoms of Abdominal distension,Abdominal discomfort, Abdominal pain,body temperature,Nausea,Vomiting. Timepoint: 5 days	—

Secondary

Measure	Time frame
Assess by CBCTimepoint: 5 days	—

Countries

India

Contacts

Public ContactDr D K Soundararajan

Government Siddha Medical College and Hospital, Palayamkottai,

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026